A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor [PDF]
et al,, Tan, Benjamin R
core +2 more sources
c-erbB-2 expression in different histological types of invasive breast carcinoma. [PDF]
S Soomro +4 more
openalex +1 more source
Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay. [PDF]
Popović L, Rossner MJ, Wehr MC.
europepmc +1 more source
Genetic alterations in early-onset invasive breast carcinomas: Correlation of c-erbB-2 amplification detected by fluorescenceIn situ hybridization with p53 accumulation and tumor phenotype [PDF]
Maryse Fiche +10 more
openalex +1 more source
Clinical value of p53, c‐erbB‐2, CEA and CA125 regarding relapse, metastasis and death in resectable non‐small cell lung cancer [PDF]
Marina Pollán +23 more
openalex +1 more source
Regulation of sebaceous gland homeostasis and sebum secretion by the ERBB receptor family. [PDF]
Hommel T, Schneider MR, Dahlhoff M.
europepmc +1 more source
Variation of hormonal receptor, pS2, c-erbB-2 and GSTπ contents in breast carcinomas under tamoxifen: a study of 74 cases [PDF]
Isabelle Soubeyran +5 more
openalex +1 more source

